United States Aortic Stent Grafts Market Outlook to 2033 - Abdominal Aortic Stent Grafts, Extension Pieces and Thoracic Aortic Stent Grafts

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Aortic Stent Grafts Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Aortic Stent Grafts Market, United States, Revenue ($m), 2018-2033
3.1.1 Extension Pieces Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Aortic Stent Grafts Market, United States, Volume (Units), 2018-2033
3.2.1 Extension Pieces Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Aortic Stent Grafts Market, United States, Average Price ($), 2018-2033
3.4 Aortic Stent Grafts Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Aortic Stent Grafts Market, United States, Company Share by Revenue ($m), 2023

4.1 W. L. Gore & Associates Inc
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Cook Medical Inc
4.3.1 Company Overview
4.4 Endologix LLC
4.4.1 Company Overview
4.5 Terumo Corp
4.5.1 Company Overview
4.6 Artivion Inc
4.6.1 Company Overview

6.1 Debt Offerings
6.1.1 Merit Medical Raises USD650 Million in Private Placement of 3% Convertible Senior Notes Due 2029
6.2 Venture Financing
6.2.1 Merit Medicine System Raises USD2 Million in Seed Financing

7.1 Corporate Communications
7.1.1 Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees
7.1.2 Dec 18, 2023: Merit Medical Announces Process for Chief Executive Officer Succession Planning
7.1.3 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer
7.1.4 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources
7.1.5 Aug 24, 2023: Endologix Announces that Lucas Buchanan Joins Board of Directors
7.1.6 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
7.2 Financial Announcements
7.2.1 Feb 28, 2024: Merit Medical Introduces 'Continued Growth Initiatives' Program and Financial Targets for Three-Year Period Ending December 31, 2026
7.2.2 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
7.2.3 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
7.2.4 Dec 12, 2023: ZimVie Announces Compatibility Between its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation
7.2.5 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
7.2.7 Sep 28, 2023: Coave Therapeutics to Present at Upcoming Conferences
7.2.6 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7.3 Government and Public Interest
7.3.1 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
7.3.2 Mar 14, 2024: Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit
7.3.3 Oct 23, 2023: Sumitomo Pharma Announces Authorization in Canada of ORGOVYX for the Treatment of Men with Advanced Prostate Cancer
7.3.4 Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference
7.4 Legal And Regulatory
7.4.1 Feb 29, 2024: Megadyne Reiterates Intended Use Population Change for Megadyne Mega Soft Universal and Universal Plus Patient Return Electrodes
7.4.2 Jul 25, 2023: Eagle Pharmaceuticals randomises patients in pneumonia drug trial
7.5 Other Significant Developments
7.5.1 May 24, 2024: iHealthScreen Developed and Validated Risk Prediction Models for Cardiovascular Diseases Using Individual’s Retinal Color Images and Health Data
7.6 Product News
7.6.1 Dec 15, 2023: Strukmyer Receives 510(K) Clearance For Comatryx Dressing - OTC

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Aortic Stent Grafts Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Extension Pieces Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Aortic Stent Grafts Market, United States, Volume (Units), 2018-2033
Table 4: Extension Pieces Market, United States, Volume (Units), 2018-2033
Table 5: Aortic Stent Grafts Market, United States, Average Price ($), 2018-2033
Table 6: Aortic Stent Grafts Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 7: Aortic Stent Grafts Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 8: Aortic Stent Grafts Market Pipeline Products
Table 9: Merit Medical Raises USD650 Million in Private Placement of 3% Convertible Senior Notes Due 2029
Table 10: Merit Medicine System Raises USD2 Million in Seed Financing
Table 11: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

Figure 1: Aortic Stent Grafts Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Extension Pieces Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Aortic Stent Grafts Market, United States, Volume (Units), 2018-2033
Figure 4: Extension Pieces Market, United States, Volume (Units), 2018-2033
Figure 5: Aortic Stent Grafts Market, United States, Company Share (%) 2023